InvestorsHub Logo
Followers 230
Posts 15196
Boards Moderated 0
Alias Born 03/30/2005

Re: None

Friday, 01/08/2021 10:51:34 AM

Friday, January 08, 2021 10:51:34 AM

Post# of 402831
Nov 2nd: The Company anticipates commencing the Brilacidin for COVID-19 clinical trial in 4Q2020.

Nov 16th: Both these submissions are part of final preparations for the Company’s multinational Phase 2 clinical trial of Brilacidin for COVID-19, which is on track to commence in 2020 upon gaining required approvals.

Nov 30th: Missing

Dec 21st: Missing

What happened between Nov 16th & Nov 30th? Something happened along the way to P2. Just like something happened to the grant in collaboration with the RBL. The grant didn't have enough data and the RBL had an unnamed internal blip that caused the delay, so filing a premature grant app had nothing to do with IPIX.

IPIX calling for human trials with 6 or 7 weeks left to the year and then act like it was never said? I would love for there to be secretive trials going on and hospitals willing to go along with the shroud of secrecy even though there is an ethical obligation to report the study. Makes sense


the above is all IMHO (consider this my safe harbor statement)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News